We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CRSP market cap is 3.87B. The company's latest EPS is USD -1.8036 and P/E is -25.22.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 70M | 0 | 201.21M | 504k | 517k |
Operating Income | -76.82M | -111.74M | 89.58M | -115.87M | -125.12M |
Net Income | -77.74M | -112.15M | 89.35M | -116.59M | -126.41M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 289.59M | 719k | 914.96M | 1.2M | 371.21M |
Operating Income | 67.31M | -348.06M | 379.53M | -650.5M | -150.72M |
Net Income | 66.86M | -348.87M | 377.66M | -650.18M | -153.61M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 2.2B | 2.09B | 2.23B | 2.44B | 2.34B |
Total Liabilities | 380.99M | 359.04M | 346.77M | 355.08M | 358.9M |
Total Equity | 1.82B | 1.73B | 1.88B | 2.08B | 1.98B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.07B | 1.83B | 2.75B | 2.24B | 2.23B |
Total Liabilities | 127.33M | 163.73M | 352.42M | 367.58M | 346.77M |
Total Equity | 939.43M | 1.66B | 2.4B | 1.88B | 1.88B |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -124.45M | -164.3M | -260.38M | 109.75M | 14.17M |
Investing | 334.75M | 456.1M | 374.65M | -97.8M | -224.71M |
Financing | 22.17M | 23.73M | 62.66M | 305.93M | 305.47M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 56.68M | -238.37M | 538.97M | -495.74M | -260.38M |
Investing | 1.33M | -541.17M | -1.04B | -258.66M | 374.65M |
Financing | 430.98M | 1.02B | 250.95M | 38.59M | 62.66M |
Market Cap | 3.87B |
Price to Earnings Ratio | -25.22 |
Price to Sales Ratio | 10.44 |
Price to Cash Ratio | 9.95 |
Price to Book Ratio | 2.06 |
Dividend Yield | - |
Shares Outstanding | 85.17M |
Average Volume (1 week) | 1.03M |
Average Volume (1 Month) | 1.06M |
52 Week Change | 7.21% |
52 Week High | 91.10 |
52 Week Low | 37.55 |
Spread (Intraday) | 0.53 (1.15%) |
Company Name | CRISPR Therapeutics AG |
Address |
baarerstrasse 14 zug 6300 |
Website | https://www.crisprtx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions